The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist

被引:47
作者
Rebuffat, AG
Tam, S
Nawrocki, AR
Baker, ME
Frey, BM
Frey, FJ
Odermatt, A
机构
[1] Univ Bern, Dept Clin Res, Div Nephrol & Hypertens, CH-3010 Bern, Switzerland
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
glucocorticoid receptor; mineralocorticoid receptor; 11 beta-hydroxysteroid dehydrogenase; dexamethasone; cortisol;
D O I
10.1016/j.mce.2003.11.027
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dexamethasone (Dex) is a potent and long-acting glucocorticoid in terms of anti-inflammatory activity without substantial sodium retaining effect. Here, we examine the ability of the 11beta-hydroxyglucocorticoids Dex and cortisol and their 11-keto forms 11-ketodexamethasone (11-ketoDex) and cortisone to bind to glucocorticoid receptors (GR) and mineralocorticoid receptors (MR) and to mediate nuclear translocation at id transactivation of a reporter-gene. Unlike cortisone, the 11-ketosteroid 11-ketoDex acts as a potent GR agonist, comparable to Dex and cortisol. Transactivation of MR by Dex or 11-ketoDex was weak or undetectable, despite efficient binding and induction of nuclear translocation. 11beta-HSD2 protects MR and GR from inappropriate occupation by cortisol; it is, however, unable to prevent activation of GR by 11-ketoDex. The finding that 11-ketoDex is a specific GR agonist may explain the potent glucocorticoid effect of Dex in tissues expressing 11beta-HSD2 including kidney and colon and also in certain tumor cells. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 36 条
[1]   CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR [J].
ARRIZA, JL ;
WEINBERGER, C ;
CERELLI, G ;
GLASER, TM ;
HANDELIN, BL ;
HOUSMAN, DE ;
EVANS, RM .
SCIENCE, 1987, 237 (4812) :268-275
[2]   Anti-inflammatory actions of glucocorticoids: molecular mechanisms [J].
Barnes, PJ .
CLINICAL SCIENCE, 1998, 94 (06) :557-572
[3]   Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo [J].
Best, R ;
Nelson, SM ;
Walker, BR .
JOURNAL OF ENDOCRINOLOGY, 1997, 153 (01) :41-48
[4]   Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition [J].
Bledsoe, RK ;
Montana, VG ;
Stanley, TB ;
Delves, CJ ;
Apolito, CJ ;
McKee, DD ;
Consler, TG ;
Parks, DJ ;
Stewart, EL ;
Willson, TM ;
Lambert, MH ;
Moore, JT ;
Pearce, KH ;
Xu, HE .
CELL, 2002, 110 (01) :93-105
[5]   Evidence using a green fluorescent protein-glucocorticoid receptor chimera that the RAN/TC4 GTPase mediates an essential function independent of nuclear protein import [J].
Carey, KL ;
Richards, SA ;
Lounsbury, KM ;
Macara, IG .
JOURNAL OF CELL BIOLOGY, 1996, 133 (05) :985-996
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]   11β-hydroxysteroid dehydrogenase types 1 and 2:: An important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids [J].
Diederich, S ;
Eigendorff, E ;
Burkhardt, P ;
Quinkler, M ;
Bumke-Vogt, C ;
Rochel, M ;
Seidelmann, D ;
Esperling, P ;
Oelkers, W ;
Bähr, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (12) :5695-5701
[8]   Metabolism of dexamethasone in the human kidney: Nicotinamide adenine dinucleotide-dependent 11 beta-reduction [J].
Diederich, S ;
Hanke, B ;
Oelkers, W ;
Bahr, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) :1598-1602
[9]   11-BETA-HYDROXYSTEROID DEHYDROGENASE ACCOUNTS FOR LOW PREDNISOLONE/PREDNISONE RATIOS IN THE KIDNEY [J].
ESCHER, G ;
FREY, FJ ;
FREY, BM .
ENDOCRINOLOGY, 1994, 135 (01) :101-106
[10]   Subcellular localization of mineralocorticoid receptors in living cells:: Effects of receptor agonists and antagonists [J].
Fejes-Tóth, G ;
Pearce, D ;
Náray-Fejes-Tóth, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (06) :2973-2978